Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease

Alzheimer Disease and Associated Disorders

Volumn 23, Issue 1, 2009, Pages 82-87

  Geschwind, Michael D ^a   Potter, Christopher A ^a   Sattavat, Mamta ^b   Garcia, Paul A ^a   Rosen, Howard J ^a   Miller, Bruce L ^b   De Armond, Stephen J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asymmetric MRI; CJD; Creutzfeldt Jakob disease; Diffusion weighted imaging; EEG; MRI pathology correlation; Prion; PrPSc

Indexed keywords

AGED; ARTICLE; AUTOPSY; CASE REPORT; CLINICAL EXAMINATION; CORRELATION ANALYSIS; CREUTZFELDT JAKOB DISEASE; DIFFUSION WEIGHTED IMAGING; ELECTROENCEPHALOGRAM; FEMALE; GLIOSIS; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; PRIORITY JOURNAL;

AGED; ATRIAL FIBRILLATION; BRAIN; CREUTZFELDT-JAKOB SYNDROME; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; STROKE;

EID: 62949172413     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31818323ef     Document Type: Article

References (44)

1. Prusiner SB. Prions. Proc Natl Acad Sci USA. 1998;95:13363-13383.
2. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004;I63:443-449.
3. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005;26:1551-1562.
4. Kretzschmar HA, Ironside JW, DeArmond SJ, et al. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 1996;53:913-920.
5. Bouzamondo E, Milroy AM, Ralston HJ III, et al. Selective neuronal vulnerability during experimental scrapie infection: insights from an ultrastructural investigation. Brain Res. 2000;874:210-215.
6. Ishikura N, Clever JL, Bouzamondo-Bernstein E, et al. Notch-1 activation and dendritic atrophy in prion disease. Proc Natl Acad Sci USA. 2005;102:886-891.
7. Jeffrey M, Halliday WG, Bell J, et al. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol. 2000;26:41-54.
8. Masters CL, Richardson EP Jr. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain. 1978;101:333-344.
9. Jendroska K, Heinzel FP, Torchia M, et al. Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology. 1991;41:1482-1490.
10. Haik S, Dormont D, Faucheux BA, et al. Prion protein deposits match magnetic resonance imaging signal abnormalities in Creutzfeldt-Jakob disease. Ann Neurol. 2002;51: 797-799.
11. Iwasaki Y, Ikeda K, Tagaya N, et al. Magnetic resonance imaging and neuropathological findings in two patients with Creutzfeldt-Jakob disease. J Neural Sci. 1994;126:228-231.
12. Russmann H, Vingerhoets F, Miklossy J, et al. Sporadic Creutzfeldt-Jakob disease: a comparison of pathological findings and diffusion weighted imaging. J Neurol. 2005;252: 338-342.
13. Mittal S, Farmer P, Kalina P, et al. Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. Arch Neurol. 2002;59:128-134.
14. Urbach H, Klisch J, Wolf HK, et al. MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology. 1998;40:65-70.
15. Mahoney F, Barthel D. Functional evaluation: Barthel index. MD State Med J. 1965;14:61-65.
16. Kascsak RJ, Rubenstein R, Merz PA, et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol. 1987;61:3688-3693.
17. Carlson GA, Ebeling C, Yang S-L, et al. Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Nail Acad Sci USA. 1994;91:5690-5694.
18. Gundersen HJ, Jensen EB, Kieu K, et al. The efficiency of systematic sampling in stereology-reconsidered. J Microsc. 1999; 193(Pt 3):199-211.
19. Glosser G, Zwil AS, Glosser DS, et al. Psychiatric aspects of temporal lobe epilepsy before and after anterior temporal lobectomy. J Neurol Neurosurg Psychiatry. 2000;68:53-58.
20. Demaerel P, Baert AL, Vanopdenbosch L, et al. Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease. Lancet. 1997;349:847-848.
21. Ukisu R, Kushihashi T, Kitanosono T, et al. Serial diffusion-weighted MRI of Creutzfeldt-Jakob disease. Am J Roentgenol. 2005;184:560-566.
22. Tschampa HJ, Kallenberg K, Urbach H, et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain. 2005;128(Pt 9):2026-2033.
23. Demaerel P, Heiner L, Robberecht W, et al. Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease. Neurology. 1999;52:205-208.
24. Burdette JH, Elster AD, Ricci PE. Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology. 1999;212: 333-339.
25. Chung YL, Williams A, Ritchie D, et al. Conflicting MRI signals from gliosis and neuronal vacuolation in prion diseases. Neuroreport. 1999;10:3471-3477.
26. Bahn MM, Parchi P. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol. 1999;56:577-583.
27. Engelbrecht V, Scherer A, Rassek M, et al. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology. 2002;222:410-418.
28. Chen CY, Lee KW, Lee CC, et al. Heroin-induced spongiform leukoencephalopathy: value of diffusion MR imaging. J Comput Assist Tomogr. 2000;24:735-737.
29. Wolters EC, van Wijngaarden GK, Stam FC, et al. Leucoence-phalopathy after inhaling "heroin" pyrolysate. Lancet. 1982;2: 1233-1237.
30. Mourmans J, Majoie CB, Barth PG, et al. Sequential MR imaging changes in nonketotic hyperglycinemia. AJNR Am J Neuroradiol. 2006;27:208-211.
31. de Coo IF, Gabreels FJ, Renier WO, et al. Canavan disease: neuromorphological and biochemical analysis of a brain biopsy specimen. Clin Neuropathol. 1991;10:73-78.
32. Holton JL, Revesz T, Crooks R, et al. Evidence for pathological involvement of the spinal cord in motor neuron disease-inclusion dementia. Acta Neuropathol (Berl). 2002;103: 221-227.
33. Brun A, Passant U. Frontal lobe degeneration of non-Alzheimer type: structural characteristics, diagnostic criteria and relation to other frontotemporal dementias. Acta Neurol Scand Suppl. 1996;168:28-30.
34. Lampert PW, Gajdusek DC, Gibbs CJ Jr. Subacute spongiform virus encephalopathies. Scrapie, kuru and Creutzfeldt-Jakob disease: a review. Am J Pathol. 1972;68:626-652.
35. DeArmond SJ, Kretzschmar HA, Prusiner SB. Prion diseases. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. 7th ed. London: Arnold; 2002:273-323.
36. Moseley ME, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion-and T2-weighted MRI and spectroscopy. Magn Reson Med. 1990;14:330-346.
37. Naslavsky N, Stein R, Yanai A, et al. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem. 1997;272: 6324-6331.
38. Gelal F, Calli C, Apaydin M, et al. van der Knaap's leukoencephalopathy: report of five new cases with emphasis on diffusion-weighted MRI findings. Neuroradiology. 2002;44: 625-630.
39. Yee AS, Simon JH, Anderson CA, et al. Diffusion-weighted MRI of right-hemisphere dysfunction in Creutzfeldt- Jakob disease. Neurology. 1999;52:1514-1515.
40. De Simone A, Dodson GG, Verma CS, et al. Prion and water: tight and dynamical hydration sites have a key role in structural stability. Proc Natl Acad Sci USA. 2005;102: 7535-7540.
41. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136-144.
42. Liu H, Farr-Jones S, Ulyanov NB, et al. Solution structure of Syrian hamster prion protein rPrP(90-231). Biochemistry (Mosc). 1999;38:5362-5377.
43. Heller J, Kolbert AC, Larsen R, et al. Solid-state NMR studies of the prion protein H1 fragment. Protein Sci. 1996;5: 1655-1661.
44. Inouye H, Bond J, Baldwin MA, et al. Structural changes in a hydrophobic domain of the prion protein induced by hydration and by ala- > Val and pro- > Leu substitutions. J Mol Biol. 2000;300:1283-1296.